Stock GUTS FRACTYL HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Fractyl Health, Inc.

Equities

GUTS

US35168W1036

Market Closed - Nasdaq
Other stock markets
 21:00:00 18/06/2024 BST 		5-day change 1st Jan Change
5.38 USD -0.74% Intraday chart for Fractyl Health, Inc. -11.80% 0.00%
05-20 Fractyl Health, Inc. Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva At Digestive Disease Week 2024 CI
05-13 Earnings Flash (GUTS) FRACTYL HEALTH Reports Q1 Revenue $33,000 MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
FRACTYL HEALTH, INC. Stock Fractyl Health, Inc.
 258M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 112B
ARGENX SE Stock argenx SE
 22.57B -
BIONTECH SE Stock BioNTech SE
 20.82B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 16.3B -
  1. Stock Market
  2. Equities
  3. GUTS Stock
  4. Charts Fractyl Health, Inc.
  5. Sector Chart